PenguinMan/ARXIV huggingface dataset:
Balancing control: a Bayesian interpretation of habitual and goal-directed behavior
Authors: Schwöbel, S.; Markovic, D.; Smolka, M. N.; Kiebel, S. J.
Category: neuroscience
Date: 2020-09-08

In everyday life, our behavior varies on a continuum from automatic and habitual to deliberate and goal-directed. Recent evidence suggests that habit formation and relearning of habits operate in a context-dependent manner: Habit formation is promoted when actions are performed in a specific context, while breaking off habits is facilitated after a context change. It is an open question how one can computationally model the brains balancing between context-specific habits and goal-directed actions. Here, we propose a hierarchical Bayesian approach for control of a partially observable Markov decision process that enables conjoint learning of habits and reward structure in a context-specific manner. In this model, habit learning corresponds to an updating of priors over policies and interacts with the learning of the outcome contingencies. Importantly, the model is solely built on probabilistic inference, which effectively provides a simple explanation of how the brain may balance contributions of habitual and goal-directed control. We illustrated the resulting behavior using agent-based simulated experiments, where we replicated several findings of devaluation, extinction, and renewal experiments, as well as the so-called two-step task which is typically used with human participants. In addition, we show how a single parameter, the habitual tendency, can explain individual differences in habit learning and the balancing between habitual and goal-directed control. Finally, we discuss the link of the proposed model to other habit learning models and implications for understanding specific phenomena in substance use disorder.
A Systems Approach Identifies Enhancer of Zeste Homolog 2 (EZH2) as a Protective Factor in Epilepsy
Authors: Khan, N.; Schoenike, B.; Grabenstatter, H.; Basu, T.; Rodriguez, G.; Sindic, C.; Johnson, M.; Wallace, E.; Maganti, R.; Dingledine, R.; Roopra, A.
Category: neuroscience
Date: 2019-11-11

Complex neurological conditions can give rise to large scale transcriptomic changes that drive disease progression. It is likely that alterations in one or a few transcription factors or cofactors underlie these transcriptomic alterations. Identifying the driving transcription factors/cofactors is a non-trivial problem and a limiting step in the understanding of neurological disorders. Epilepsy has a prevalence of 1% and is the fourth most common neurological disorder. While a number of anti-seizure drugs exist to treat seizures symptomatically, none is curative or preventive. This reflects a lack of understanding of disease progression. We used a novel systems approach to mine transcriptome profiles of rodent and human epileptic brain samples to identify regulators of transcriptional networks in the epileptic brain. We find that Enhancer of Zeste Homolog 2 (EZH2) regulates differentially expressed genes in epilepsy across multiple rodent models of acquired epilepsy. EZH2 undergoes a prolonged upregulation in the epileptic brain. A transient inhibition of EZH2 immediately after seizure induction robustly increases spontaneous seizure burden weeks later. Thus, EZH2 upregulation is a protective response mounted after a seizure. These findings are the first to characterize a role for EZH2 in opposing epileptogenesis and debut a bioinformatic approach to identify nuclear drivers of complex transcriptional changes in disease.\n\nAuthor SummaryEpilepsy is the fourth most common neurological disorder and has been described since the time of Hippocrates. Despite this, no treatments exist to stop epilepsy progression. This is fundamentally due to the complex nature of the disease. Epilepsy is associated with hundreds if not thousands of gene expression changes in the brain that are likely driven by a few key master regulators called transcription factors and cofactors. Finding the aberrantly acting factors is a complex problem that currently lacks a satisfactory solution. We used a novel datamining tool to define key master regulators of gene expression changes across multiple epilepsy models and patient samples. We find that a nuclear enzyme, EZH2, regulates a large number of genes in the rodent and patient epileptic brain and that its function is protective. Thus, inhibiting EZH2 greatly exacerbates seizure burden. This is the first report of a novel datamining tool to define drivers of large-scale gene changes and is also the first report of EZH2 induction as an endogenous protective response in the epilepsy.
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington’s disease
Authors: McCormick, P.; Gines, S.; Guzman, M.; Ferre, S.; Canela, E. I.; Chiarlone, A.; Casado, V.; Cortes, A.; Moreno, E.; Lluis, C.; Alberch, J.; Puigdellivol, M.; Scarselli, M.; Moreno, D.; Gasperini, P.; Botta, J.; Howell, L.
Category: neuroscience
Date: 2019-11-11

Early Huntingtons disease (HD) include over-activation of dopamine D1 receptors (D1R), producing an imbalance in dopaminergic neurotransmission and cell death. To reduce D1R over-activation, we present a strategy based on targeting complexes of D1R and histamine H3 receptors (H3R). Using an HD striatal cell model and HD organotypic brain slices we found that D1R-induced cell death signaling and neuronal degeneration, are mitigated by an H3R antagonist. We demonstrate that the D1R-H3R heteromer is expressed in HD animal models at early but not late stages of HD, correlating with HD progression. In accordance, we found this target expressed in human control subjects and low-grade HD patients. Finally, treatment of HD mice with an H3R antagonist prevented cognitive and motor learning deficits, as well as the loss of heteromer expression. Taken together, our results indicate that D1R - H3R heteromers play a pivotal role in dopamine signaling and represent novel targets for treating HD.\n\nImpact StatementProgression of Huntingtons disease can be slowed by altering dopamine signalling through the Dopamine 1 receptor - Histamine 3 receptor heteromer.
Expecting social punishment facilitates control over a decision under uncertainty by recruiting medial prefrontal cortex
Authors: Kim, J.; Jeong, B.
Category: neuroscience
Date: 2019-11-11

In many decision-making situations, uncertainty facilitates suboptimal choices. However, when individuals are in a socially dangerous situation such that wrong choice would lead to a social punishment such as blame of the supervisor, they might try to minimize suboptimal choices to avoid it. In this functional MRI study, 46 participants performed a choice task in which the probability of a correct choice with a given cue and the conditional probability of blame feedback (by making an incorrect choice) changed continuously. Using computational models of behavior, we found that participants optimized their decision by suppressing the decision noise induced by uncertainty. Simultaneously, expecting blame significantly deteriorated participants mood. Model-based fMRI analyses and dynamic causal modeling revealed that the optimization mechanism based on the expectation of being blamed was controlled by a neural circuit centered on right medial prefrontal cortex. These results show novel behavioral and neural mechanisms regarding how humans optimize uncertain decisions under the expectation of being blamed that negatively influences mood.\n\nSignificance StatementPeople occasionally encounter a situation that forces us to make an optimal decision under uncertainty, which is difficult, and a failure to make a good choice might be blamed by their supervisor. Although it might be hard to make right decision, they make more effort to make a good decision, which might help them to escape from the aversive outcome. However, such kind of stressful situation influences our mood to be negative. Using the computational modelling, we showed that participants computed how it is likely to be blamed and this computation motivated people to control uncertainty-induced decision noise by recruiting a neural circuit centered on the medial prefrontal cortex. However, an expectation of being blamed significantly deteriorated participants mood.
Reduced Auditory Steady State Responses in Autism Spectrum Disorder
Authors: Seymour, R. A.; Rippon, G.; Gooding-Williams, G.; Sowman, P. F.; Kessler, K.
Category: neuroscience
Date: 2020-06-10

BackgroundAuditory steady state responses (ASSRs) are elicited by clicktrains or amplitude-modulated tones, which entrain auditory cortex at their specific modulation rate. Previous research has reported reductions in ASSRs at 40Hz for autism spectrum disorder (ASD) participants and first-degree relatives of people diagnosed with ASD [1,2].

MethodsUsing a 1.5s-long auditory clicktrain stimulus, designed to elicit an ASSR at 40Hz, this study attempted to replicate and extend these findings. Magnetencephalography (MEG) data were collected from 18 adolescent ASD participants and 18 typically developing controls.

ResultsThe ASSR localised to bilateral primary auditory regions. Regions of interest were thus defined in left and right primary auditory cortex (A1). While the transient gamma-band response (tGBR) from 0-0.1s following presentation of the clicktrain stimulus was not different between groups, for either left or right A1, the ASD group had reduced oscillatory power at 40Hz from 0.5 to 1.5s post-stimulus onset, for both left and right A1. Additionally, the ASD group had reduced inter-trial coherence (phase consistency over trials) at 40Hz from 0.64-0.82s for right A1 and 1.04-1.22s for left A1.

LimitationsIn this study, we did not conduct a clinical autism assessment (e.g. the ADOS), and therefore it remains unclear whether ASSR power and/or ITC are associated with the clinical symptoms of ASD.

ConclusionOverall, our results support a specific reduction in ASSR oscillatory power and inter-trial coherence in ASD, rather than a generalised deficit in gamma-band responses. We argue that this could reflect a developmentally relevant reduction in non-linear neural processing.
More evidence for a long-latency mismatch response in urethane-anaesthetised mice
Authors: O'Reilly, J. A.; Angsuwatanakul, T.
Category: neuroscience
Date: 2019-11-11

Prolonged electrophysiological responses to oddball stimuli have recently been observed from anaesthetised rodents. This deviant-related activity is found to extend through 200 to 700 ms post-stimulus; a window typically obstructed from analysis by the response to subsequent stimuli in the auditory sequence. A simple methodological development in terms of difference waveform computation using two adjoining evoked responses has enabled visualisation of this activity over a longer window of analysis than previously available. In the present study, the double-epoch subtraction technique was retroactively applied to data from 13 urethane-anaesthetised mice. Oddball paradigm waveforms were compared with those of a many-standards control sequence, confirming that oddball stimuli evoked long-latency potentials that did not arise from standard or control stimuli. Statistical tests were performed at every time point from 0 to 700 ms post stimuli to highlight regions of significant difference. Oddball-induced mismatch responses were found to display significantly greater long-latency potentials than identical stimuli presented in an equal-probability context. As such, it may be concluded that long-latency potentials were evoked by the oddball condition. How this feature of the anaesthetised rodent mismatch response relates to human mismatch negativity is unclear, although it may be tentatively linked to the human P3a component, which is considered to emerge downstream from mismatch negativity.
Schizophrenia patients show aberrant brain dynamics associated with gestalt-perception and corollary discharge: Reflections from ERP and fMRI findings
Authors: Sasidharan, A.; Nair, A. K.; Marigowda, V.; Lukose, A.; John, J. P.; Kutty, B. M.
Category: neuroscience
Date: 2019-11-11

BackgroundSchizophrenia is a disorder of higher mental attributes, and is characterized by psychotic symptoms that are believed to involve a basic inability to make valid predictions about expected sensations and experiences. These have been reported separately while monitoring either externally generated environmental patterns (e.g. gestalt-perception) or self-generated sensory experiences (e.g. corollary-discharge). As the pathophysiology behind predictive dysfunction is better viewed as an aberration in brains functional synchrony, a whole brain assessment using electroencephalographic (EEG) event related potential (ERP) and functional magnetic resonance imaging (fMRI) techniques, would offer a wider perspective to brain network abnormalities in schizophrenia.\n\nMethodWe used our lab-developed game-based task which presents degraded two-tone images to assess gestalt-perception, and simultaneously alters the congruency between participants button-press response and its auditory feedback to assess corollary-discharge. In both patients with schizophrenia and age-matched healthy controls, we explored event-related changes in an EEG-ERP study (n=21 each) and whole brain functional connectivity changes in a fMRI study (patients,n=12; controls,n=16), using the same task.\n\nResultsPatients showed reduced event-related EEG dynamics during both the error-prediction conditions (gestalt-perception and corollary-discharge), which include reduction in average waveforms (around N170 and N1-P2 complex, respectively) and altered theta dynamics (power and phase). Source-level EEG measures were clustered around the cingulo-insular network. fMRI functional connectivity analysis also found the abnormality in these brain regions, forming significantly weak connections with right insular/opercular cortex.\n\nConclusionsThis is the first study to explore  thalamo-cortical dysfunction hypothesis in schizophrenia by integrating prediction-error-coding during perception ( gestalt-perception) and action ( corollary-discharge) using two neuroimaging modalities (EEG-ERP and fMRI). Besides adding to the knowledgebase of schizophrenia research, our novel task design and findings on theta-oscillation could benefit in the development of effective neuromodulatory therapeutic tools for patients with schizophrenia such as neurofeedback and transcranial brain stimulation.
Trading Mental Effort for Confidence in the Metacognitive Control of Value-Based Decision-Making
Authors: Lee, D.; Daunizeau, J.
Category: neuroscience
Date: 2021-02-09

Why do we sometimes opt for actions or items that we do not value the most? Under current neurocomputational theories, such preference reversals are typically interpreted in terms of errors that arise from the unreliable signaling of value to brain decision systems. But, an alternative explanation is that people may change their mind because they are reassessing the value of alternative options while pondering the decision. So, why do we carefully ponder some decisions, but not others? In this work, we derive a computational model of the metacognitive control of decisions or MCD. In brief, we assume that fast and automatic processes first provide initial (and largely uncertain) representations of options values, yielding prior estimates of decision difficulty. These uncertain value representations are then refined by deploying cognitive (e.g., attentional, mnesic) resources, the allocation of which is controlled by an effort-confidence tradeoff. Importantly, the anticipated benefit of allocating resources varies in a decision-by-decision manner according to the prior estimate of decision difficulty. The ensuing MCD model predicts response time, subjective feeling of effort, choice confidence, changes of mind, and choice-induced preference change and certainty gain. We test these predictions in a systematic manner, using a dedicated behavioral paradigm. Our results provide a quantitative link between mental effort, choice confidence, and preference reversals, which could inform interpretations of related neuroimaging findings.
A framework for closed-loop neurofeedback for real-time EEG decoding
Authors: Tuckute, G.; Hansen, S. T.; Kjaer, T. W.; Hansen, L. K.
Category: neuroscience
Date: 2019-11-11

Neurofeedback based on real-time brain imaging allows for targeted training of brain activity with demonstrated clinical applications. A rapid technical development of electroen-cephalography (EEG)-based systems and an increasing interest in cognitive training has lead to a call for accessible and adaptable software frameworks. Here, we present and outline the core components of a novel open-source neurofeedback framework based on scalp EEG signals for real-time neuroimaging, state classification and closed-loop feedback.\n\nThe software framework includes real-time signal preprocessing, adaptive artifact rejection, and cognitive state classification from scalp EEG. The framework is implemented using exclusively Python source code to allow for diverse functionality, high modularity, and easy extendibility of software development depending on the experimenters needs.\n\nAs a proof of concept, we demonstrate the functionality of our new software framework by implementing an attention training paradigm using a consumer-grade, dry-electrode EEG system. Twenty-two participants were trained on a single neurofeedback session with behavioral pre- and post-training sessions within three consecutive days. We demonstrate a mean decoding error rate of 34.3% (chance=50%) of subjective attentional states. Hence, cognitive states were decoded in real-time by continuously updating classification models on recently recorded EEG data without the need for any EEG recordings prior to the neurofeedback session.\n\nThe proposed software framework allows a wide range of users to actively engage in the development of novel neurofeedback tools to accelerate improvements in neurofeedback as a translational and therapeutic tool.
Inter-hemispheric inhibition in stroke survivors is related to fatigue and cortical excitability
Authors: Ondobaka, S.; Ward, N.; Kuppuswamy, A.
Category: neuroscience
Date: 2019-11-11

ObjectivePersistent post-stroke fatigue is a major debilitating condition that has been linked to low corticomotor excitability and aberrant attention, both phenomena that are associated with the inter-hemispheric inhibition balance in the brain. In this study, we examined the relationship between inter-hemispheric inhibitory effective connectivity, motor cortex excitability and chronic persistence of post-stroke fatigue.\n\nMethodsWe tested eighteen non-depressed stroke survivors with minimal motoric and cognitive impairments using spectral dynamic causal modelling (spDCM) of  resting state magnetic resonance imaging (rs-fMRI) and transcranial magnetic stimulation (TMS) measures of cortical excitability. We also assessed the levels of non-exercise induced, persistent fatigue using Fatigue Severity Scale (FSS) - a self-report questionnaire which has been widely applied and validated across different conditions. To understand neural effective connectivity mechanisms involved in fatigue and corticomotor excitability we examined the balance in inhibitory connectivity between homologue regions in M1, anterior insula, caudate and thalamus of the resting brain.\n\nResultsInter-hemispheric inhibition balance between left and right M1 accounted for 67% of variability in the reported fatigue (R=.82, p<0.001). Inter-hemispheric inhibition balance in M1 also accounted for 54% of variability in the corticomotor excitability characterised by individual resting motor thresholds (R=.74, p<0.001), a measure that has been associated with subjective fatigue reports. Other examined inter-hemispheric connections did not show significant relationships with either fatigue or cortical excitability measures.\n\nConclusionOur findings suggest that the balance in inter-hemispheric effective connectivity between primary motor regions is involved in regulation of corticomotor excitability and could explain subjective post-stroke fatigue.
Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression
Authors: Canet-Pons, J.; Sen, N.-E.; Arsovic, A.; Almaguer-Mederos, L.-E.; Halbach, M. V.; Key, J.; Doering, C.; Kerksiek, A.; Picchiarelli, G.; Cassel, R.; Rene, F.; Dieterle, S.; Hein-Fuchs, N.; Koenig, R.; Dupuis, L.; Luetjohann, D.; Gispert-Sanchez, S.; Auburger, G.
Category: neuroscience
Date: 2019-11-11

Large polyglutamine expansions in Ataxin-2 (ATXN2) cause multi-system nervous atrophy in Spinocerebellar Ataxia type 2 (SCA2). Intermediate size expansions carry a risk for selective motor neuron degeneration, known as Amyotrophic Lateral Sclerosis (ALS). Conversely, the depletion of ATXN2 prevents disease progression in ALS. Although ATXN2 interacts directly with RNA, and in ALS pathogenesis there is a crucial role of RNA toxicity, the affected functional pathways remain ill defined. Here, we examined an authentic SCA2 mouse model with Atxn2-CAG100-KnockIn for a first definition of molecular mechanisms in spinal cord pathology. Neurophysiology of lower limbs detected sensory neuropathy rather than motor denervation. Triple immunofluorescence demonstrated cytosolic ATXN2 aggregates sequestrating TDP43 and TIA1 from the nucleus. In immunoblots, this was accompanied by elevated CASP3, RIPK1 and PQBP1 abundance. RT-qPCR showed increase of Grn, Tlr7 and Rnaset2 mRNA versus Eif5a2, Dcp2, Uhmk1 and Kif5a decrease. These SCA2 findings overlap well with known ALS features. Similar to other ataxias and dystonias, decreased mRNA levels for Unc80, Tacr1, Gnal, Ano3, Kcna2, Elovl5 and Cdr1 contrasted with Gpnmb increase. Preterminal stage tissue showed strongly activated microglia containing ATXN2 aggregates, with parallel astrogliosis. Global transcriptome profiles from stages of incipient motor deficit versus preterminal age identified molecules with progressive downregulation, where a cluster of cholesterol biosynthesis enzymes including Dhcr24, Msmo1, Idi1 and Hmgcs1 was prominent. Gas chromatography demonstrated a massive loss of crucial cholesterol precursor metabolites. Overall, the ATXN2 protein aggregation process affects diverse subcellular compartments, in particular stress granules, endoplasmic reticulum and receptor tyrosine kinase signaling. These findings identify new targets and potential biomarkers for neuroprotective therapies.